← Back to Search

Educational Outreach for COVID-19 Testing and Vaccination (INFORMED Trial)

N/A
Waitlist Available
Led By Janice Y Tsoh, PhD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 18 and older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 16
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare two methods of educating people about getting tested for COVID-19, one with text messaging and one with text messaging plus support from a community health worker.

Who is the study for?
This trial is for Asian Americans aged 18 or older who identify as Chinese, Hmong, or Vietnamese. Participants must be able to read/speak English, Chinese (Cantonese/Mandarin), Hmong, or Vietnamese and have access to a mobile phone for text messages. Those unwilling to receive texts are excluded.
What is being tested?
The study tests the 'INFORMED' intervention against standard SMS text messaging with added support from Lay Health Workers (LHW). It aims to improve knowledge about COVID-19 testing and reduce hesitancy in getting tested through educational outreach.
What are the potential side effects?
Since this trial involves educational activities rather than medical treatments, there are no traditional side effects. However, participants may experience an increase in screen time due to reading texts.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 16
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 16 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Proportion of participants who have decisional conflicts for getting tested of COVID-19
Secondary study objectives
COVID-19 Testing Knowledge Score
Proportion of participants who has been tested for COVID-19 during the study period.
Other study objectives
Proportion of participants who have decisional conflicts for getting vaccinated for COVID-19

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: INFORMEDExperimental Treatment1 Intervention
Participants will receive a weekly SMS Text or instant message on a topic related to COVID-19 testing as described in the "Text Messaging Only." In addition, participants will receive a Lay Health Worker (LHW) Educational Outreach Program, which includes 2 group sessions via video calls like Zoom or another video conferencing platform and 2 follow-up contacts via telephone, text or other media assignment.
Group II: Text Messaging OnlyActive Control1 Intervention
Participants will receive a weekly SMS Text or instant message on a topic related to COVID-19 testing over 12 weeks. In addition, participants will receive as-needed messages on updates of COVID-19 testing related information. The messages will be responsive to the rapid evolving developments and changes related to COVID-19 testing guidelines. Some of the messages will include a link to allow participants to get to the entire message/information on the study website.

Find a Location

Who is running the clinical trial?

University of California, DavisOTHER
943 Previous Clinical Trials
4,755,444 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,586 Previous Clinical Trials
3,328,286 Total Patients Enrolled
Chinese Community Health Resource CenterOTHER
3 Previous Clinical Trials
2,987 Total Patients Enrolled
~60 spots leftby Nov 2025